Stock Events

Stock Events

HLS Therapeutics (HLTRF) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.18

-0.15

-0.12

-0.09

Details

Expected EPS

-0.119776

Actual EPS

-0.14

Surprise EPS

-0.02

Surprise Percent

+16.88%

Description

HLS Therapeutics (HLTRF) has reported earnings of -0.14 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.